Hyperglycemia is a marker for poor outcome in the postoperative pediatric cardiac patient

Andrew R Yates1, Peter C Dyke, Roozbeh Taeed

  • 1Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH 43205-2696, USA. yatesa@pediatrics.ohio-state.edu

Insights

Postoperative hyperglycemia in pediatric cardiac surgery patients is linked to worse outcomes, including longer hospital stays and increased mortality. Strict blood sugar control may be beneficial for these young patients.

Area of Science:

  • Pediatric Critical Care Medicine
  • Pediatric Cardiac Surgery
  • Endocrinology

Background:

  • Hyperglycemia is a known risk factor for morbidity and mortality in critical care.
  • Limited data exist regarding hyperglycemia in postoperative pediatric cardiac patients.

Purpose of the Study:

  • To determine the association between postoperative hyperglycemia and increased morbidity or mortality in pediatric cardiac surgery patients.

Main Methods:

  • Retrospective chart review of 184 pediatric patients (<1 year) undergoing cardiac surgery with cardiopulmonary bypass.
  • Exclusion criteria included low weight, diabetes, preoperative ECMO, transplant, and renal/liver insufficiency.

Main Results:

  • Longer duration of hyperglycemia correlated with renal/liver insufficiency, infection, CNS events, ECMO use, and death.
  • Hyperglycemia was associated with increased intensive care and hospital stay, and longer ventilator use.
  • Peak glucose levels differed significantly in patients with renal insufficiency, infection, CNS events, and mortality.

Conclusions:

  • Postoperative hyperglycemia is associated with increased morbidity and mortality in pediatric cardiac surgery patients.
  • Strict glycemic control may improve outcomes in this vulnerable population.
Abstract

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...